Healthcare News Today for Hospital and Health System Leaders | Becker's Hospital Review

New rules, tighter scrutiny: What revenue integrity has to cover in 2027

Eligibility churn and redetermination pressure remain significant for revenue cycle teams, but they’re no longer the whole story. Heading into 2027, new Medicaid community engagement and six-month renewal requirements will add eligibility complexity for affected populations, while Medicare payment updates…

Oct 28, 2026 1:00 PM - 2:00 PM CDT

Presented by:

Presenters:

Sarah Brainard, Vice President of Enterprise Solutions, Office Ally
Marji Karlin, MBA, Chief Revenue Officer, NYC Health + Hospitals
Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, FAHIMA, Assistant Vice President Revenue Integrity, Revenue Cycle, Montefiore Medical Center
Christina Slemp, DHA, MHA, MSHI, System Vice President, Revenue Cycle Operations – Financial Services, UNC Health

Register

34 more HCA hospitals go live on Meditech

HCA Healthcare now has 72 hospitals across the U.S. and U.K. running on Meditech Expanse as the health system continues a multiyear EHR rollout. The latest implementation brought 34 hospitals in HCA’s Capital and North Florida divisions onto the platform,…

HHS: Duke medical school discriminated based on race

An HHS Office for Civil Rights investigation has found the Duke School of Medicine in Durham, N.C., violated federal law by intentionally discriminating based on race in admissions. Five things to know: 1. Duke School of Medicine was notified Sept.…

Rural specialty care access at risk: How 4 systems are responding

Rural and underserved hospitals nationwide face a widening gap in specialty care. A Becker’s Healthcare survey of 100 hospital and health system leaders across roughly 30 states points to the root cause: the problem isn’t technology; it’s a shortage of…

Oct 23, 2026 11:00 AM - 12:00 PM CDT

Presented by:

Presenters:

Jeremy Cauwels, MD, Chief Medical Officer, Sanford Health
Sai Yendamuri, MD, MBA, Chief Strategy Officer; Professor and Chair of Thoracic Surgery, Roswell Park Comprehensive Cancer Center
Penni Kyte, MBA, Senior Vice President, Technology Enabled Care, Ballad Health
Chethan Sathya, MD, MSc, Co-Chair, National Specialty Care Access Coalition
Raj Narula, MD, Founder & CEO, Sevaro Health

Register

WakeMed to expand specialty pharmacy with Longitude Rx

Raleigh, N.C.-based WakeMed and Longitude Rx are working together to build out the health system’s specialty pharmacy program. The work will focus on operational readiness, accreditation preparation, quality standards and the infrastructure to support future growth and market access, according…

Indiana hospital names dual CEO-chief nursing officer

Tami Johnson, MSN, RN, has been appointed CEO and chief nursing officer of Unity Physicians Hospital in Mishawaka, Ind., effective Aug. 15. Ms. Johnson had served as chief nursing officer and chief quality officer for the past three years and…

Tylenol maker, pharmacy giants make another push to kill autism lawsuits

Kenvue and several major pharmacy and retail chains have asked the 2nd Circuit U.S. Court of Appeals to reconsider its July ruling that reinstated roughly 550 lawsuits alleging prenatal acetaminophen use contributed to autism spectrum disorder or ADHD in children,…

71 health systems with strong finances

Here are 71 health systems with strong operational metrics and solid financial positions, according to reports from credit rating agencies Fitch Ratings and Moody’s Investors Service released in 2026. Note: This is not an exhaustive list. Health systems were compiled…

Struggling Georgia hospital asks for local aid

Elbert (Ga.) Memorial Hospital has asked for a $250,000 contribution from the Elbert County Board of Commissioners to sustain the facility’s operations, including a matched contribution request from the City of Elberton, according to a Sept. 10 Facebook post from…

FDA approves 1st-of-its-kind treatment for rare muscle disease

The FDA has approved Scholar Rock’s ISEMBYLD for spinal muscular atrophy in adults and children ages 2 and older who are currently receiving a survival motor neuron 2-targeted treatment. ISEMBYLD is the first muscle-targeted treatment approved for children and adults…